Stocks & Investing
Tue, April 19, 2022
[ 12:00 AM ] - WOPRAI
Fri, October 1, 2021
Tue, June 29, 2021
Mon, March 1, 2021
[ 12:00 AM ] - WOPRAI
Mon, January 11, 2021
Tue, January 5, 2021
Wed, April 8, 2020
[ 12:00 AM ] - WOPRAI
Tue, January 29, 2019
[ 12:00 AM ] - WOPRAI
Wed, April 12, 2017
[ 12:00 AM ] - WOPRAI
Wed, January 4, 2017
Wed, March 4, 2015 Kevin DeGeeter Initiated (ANTX) at Buy and Held Target at $22 on, Apr 19th, 2022
Kevin DeGeeter of Oppenheimer, Initiated "AN2 Therapeutics, Inc." (ANTX) at Buy and Held Target at $22 on, Apr 19th, 2022.
Kevin, nor any peers, have made any analyst calls on ANTX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30